-
1
-
-
70349638608
-
-
World Health Organization. 4th edn. Geneva: World Health Organization; Report No.: WHO/HTM/TB/2009.420
-
World Health Organization. Treatment of Tuberculosis Guidelines, 4th edn. Geneva: World Health Organization; 2009. Report No.: WHO/HTM/TB/2009.420.
-
(2009)
Treatment of Tuberculosis Guidelines
-
-
-
2
-
-
0003573158
-
-
6th edn. Toronto: Canadian Lung Association, Public Health Agency of Canada, Tuberculosis Prevention and Control
-
Long RL, Ellis E. Canadian Tuberculosis Standards, 6th edn. Toronto: Canadian Lung Association, Public Health Agency of Canada, Tuberculosis Prevention and Control, 2007.
-
(2007)
Canadian Tuberculosis Standards
-
-
Long, R.L.1
Ellis, E.2
-
3
-
-
0037441632
-
Treatment of tuberculosis
-
American Thoracic Society, Infectious Diseases Society of America, Centres for Disease Control
-
American Thoracic Society, Infectious Diseases Society of America, Centres for Disease Control. Treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62.
-
(2003)
Am J Respir Crit Care Med
, vol.167
, pp. 603-662
-
-
-
4
-
-
70349634546
-
Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: A systematic review and meta-analysis
-
Menzies D, Benedetti A, Paydar A, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: A systematic review and meta-analysis. PLOS Med 2009;6:e1000146.
-
(2009)
PLOS Med
, vol.6
-
-
Menzies, D.1
Benedetti, A.2
Paydar, A.3
-
5
-
-
0036033914
-
Therapeutic drug monitoring in the treatment of tuberculosis
-
Peloquin C. Therapeutic drug monitoring in the treatment of tuberculosis. Drugs 2002;62:2169-83. (Pubitemid 35252827)
-
(2002)
Drugs
, vol.62
, Issue.15
, pp. 2169-2183
-
-
Peloquin, C.A.1
-
6
-
-
23244459431
-
Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana
-
DOI 10.1086/431984
-
Tappero J, Bradford W, Agerton T, et al. Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana. Clin Infect Dis 2005;41:461-9. (Pubitemid 41099637)
-
(2005)
Clinical Infectious Diseases
, vol.41
, Issue.4
, pp. 461-469
-
-
Tappero, J.W.1
Bradford, W.Z.2
Agerton, T.B.3
Hopewell, P.4
Reingold, A.L.5
Lockman, S.6
Oyewo, A.7
Talbot, E.A.8
Kenyon, T.A.9
Moeti, T.L.10
Moffat, H.J.11
Peloquin, C.A.12
-
7
-
-
0036015669
-
Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia
-
van Crevel R, Alisjahbana B, de Lange WCM, et al. Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia. Int J Tuberc Lung Dis 2002;6:497-502. (Pubitemid 34601866)
-
(2002)
International Journal of Tuberculosis and Lung Disease
, vol.6
, Issue.6
, pp. 497-502
-
-
Van Crevel, R.1
Alisjahbana, B.2
De Lange, W.C.M.3
Borst, F.4
Danusantoso, H.5
Van Der, M.J.W.M.6
Burger, D.7
Nelwan, R.H.H.8
-
8
-
-
0035166747
-
Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy
-
DOI 10.1378/chest.120.5.1520
-
Mehta J, Shantaveerapa H, Byrd R, Morton S, et al. Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy. Chest 2001;120:1520-4. (Pubitemid 33078467)
-
(2001)
Chest
, vol.120
, Issue.5
, pp. 1520-1524
-
-
Mehta, J.B.1
Shantaveerapa, H.2
Byrd Jr., R.P.3
Morton, S.E.4
Fountain, F.5
Roy, T.M.6
-
9
-
-
0037614780
-
Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine
-
DOI 10.1164/rccm.200208-951OC
-
Weiner M, Burman W, Vernon A, et al. Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine. Am J Respir Crit Care Med 2003;167:1341-7. (Pubitemid 36609717)
-
(2003)
American Journal of Respiratory and Critical Care Medicine
, vol.167
, Issue.10
, pp. 1341-1347
-
-
Weiner, M.1
Burman, W.2
Vernon, A.3
Benator, D.4
Peloquin, C.A.5
Khan, A.6
Weis, S.7
King, B.8
Shah, N.9
Hodge, T.10
-
10
-
-
20944440618
-
Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis
-
DOI 10.1086/429321
-
Weiner M, Benator BW, Peloquin CA, et al. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis. Clin Infect Dis 2005;40:1481-91. (Pubitemid 40628637)
-
(2005)
Clinical Infectious Diseases
, vol.40
, Issue.10
, pp. 1481-1491
-
-
Weiner, M.1
Benator, D.2
Burman, W.3
Peloquin, C.A.4
Khan, A.5
Vernon, A.6
Jones, B.7
Silva-Trigo, C.8
Zhao, Z.9
Hodge, T.10
-
11
-
-
51449107422
-
-
Department of Health and Human Services (Accessed on July 4, 2011)
-
Department of Health and Human Services/Centers for Disease Control and Prevention. Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis, 2007. 〈http://www.cdc.gov/tb/TB-HIV-Drugs/default.htm〉 (Accessed on July 4, 2011).
-
(2007)
Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
-
-
-
12
-
-
72849124759
-
Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis
-
Boulanger C, Hollender E, Farrell K, et al. Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis. Clin Infect Dis 2009;49:1305-11.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 1305-1311
-
-
Boulanger, C.1
Hollender, E.2
Farrell, K.3
-
13
-
-
0021711632
-
Clinical pharmacokinetics of the antituberculosis drugs
-
Holdiness MR. Clinical pharmacokinetics of the antituberculosis drugs. Clin Pharmacokinet 1984;9:511-44. (Pubitemid 15211649)
-
(1984)
Clinical Pharmacokinetics
, vol.9
, Issue.6
, pp. 511-544
-
-
Holdiness, M.R.1
-
15
-
-
66949172863
-
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana
-
Chideya S, Winston C, Peloquin CA, Bradford WZ, et al. Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Clin Infect Dis 2009;48:1685-94.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 1685-1694
-
-
Chideya, S.1
Winston, C.2
Peloquin, C.A.3
Bradford, W.Z.4
-
16
-
-
0038796548
-
Managing antituberculosis drug therapy by therapeutic drug monitoring of rifampicin and isoniazid
-
DOI 10.1046/j.1445-5994.2003.00390.x
-
Ray J, Gardiner I, Marriott D. Managing antituberculosis drug therapy by therapeutic drug monitoring of rifampicin and isoniazid. Internal Med J 2003;33:229-34. (Pubitemid 36718380)
-
(2003)
Internal Medicine Journal
, vol.33
, Issue.5-6
, pp. 229-234
-
-
Ray, J.1
Gardiner, I.2
Marriott, D.3
-
17
-
-
20244364939
-
Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection
-
Sahai J, Gallicano K, Swick L, et al. Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection. Ann Intern Med 1997;127:289.
-
(1997)
Ann Intern Med
, vol.127
, pp. 289
-
-
Sahai, J.1
Gallicano, K.2
Swick, L.3
-
18
-
-
66249133047
-
Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection
-
Holland DP, Hamilton CD, Weintrob AC, et al. Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection. Pharmacotherapy 2009;29:503-10.
-
(2009)
Pharmacotherapy
, vol.29
, pp. 503-510
-
-
Holland, D.P.1
Hamilton, C.D.2
Weintrob, A.C.3
-
20
-
-
65649136872
-
Tuberculosis pharmacotherapy: Strategies to optimize patient care
-
Mitnick CD, McGee B, Peloquin CA. Tuberculosis pharmacotherapy: Strategies to optimize patient care. Expert Opin Pharmacother 2009;10:381-401.
-
(2009)
Expert Opin Pharmacother
, vol.10
, pp. 381-401
-
-
Mitnick, C.D.1
McGee, B.2
Peloquin, C.A.3
|